针对ITK的免疫重塑增强了抗CD19CAR-T细胞治疗的疗效
Zhenjun Li1, Liangcheng Lv1, Xiaoyu Yao1
1Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Laboratory of Lymphoma Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.
Cell death discovery
|March 6, 2026
概括
ITK抑制剂索克利提尼布通过改善T细胞功能和持久性来增强CAR-T细胞疗法. 这种方法可以增强抗瘤活性,为淋巴瘤和其他癌症提供更好的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体T细胞 (CAR-T) 治疗对B细胞淋巴瘤具有前景,但面临T细胞功能障碍和疲劳的挑战,限制了持久的反应.
- 在CAR-T细胞治疗中,T细胞耗尽是维持抗瘤免疫力的关键障碍.
研究的目的:
- 为了研究soquelitinib的潜力,一个选择性的布鲁顿氨酸激酶 (ITK) 抑制剂,以增强CAR-T细胞的持久性和抗瘤功能.
- 在临床前模型中评估索克利提尼布对CAR-T细胞的免疫调节作用.
主要方法:
- 流细胞计用于分析T细胞种群和疲劳标记 (TIM3,LAG3,PD-1).
- RNA测序用于基因表达分析,以评估分子变化.
- 在携带瘤的小鼠模型中评估了治疗疗效.
主要成果:
- 索克利提尼布治疗显著增加了CAR-T细胞细胞毒性和抗瘤活性,通过上调效应分子 (GZMB,TNF-α,IFN-γ).
- 抑制ITK促进了CD8+T细胞扩张,包括原始和效应子组,同时降低了疲劳标记.
- 用ITK抑制剂治疗的CAR-T细胞表现出对恶性B细胞的增强细胞毒性和改善体内生存率,延迟的T细胞耗尽表明转录因子调制 (TOX,TCF1).
结论:
- 索克利提尼布通过减轻T细胞耗尽,有效地增强CAR-T细胞的抗瘤功能和持久性.
- 索克利蒂尼布与CAR-T治疗的整合是一个有前途的策略,可以改善血液恶性瘤和潜在的固体瘤的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:27Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K